Pharma Layoffs Continue - GlaxoSmithKline to cut 5,000 jobs

fiercepharma.com — Yesterday, GlaxoSmithKline announced a big restructuring plan that will trim $1.4 billion in costs over the next four years and shrink its payroll by at least 5,000. Glaxo also plans to outsource manufacturing of its off-patent drugs, so some 40 percent of the job cuts will come in that sphere.